Thermo Fisher Scientific (Thermo Fisher Scientific) Cash-to-Debt

: 0.23 (As of Dec. 2023)

View and export this data going back to 1980. Start your Free Trial

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Thermo Fisher Scientific's cash to debt ratio for the quarter that ended in Dec. 2023 was 0.23.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Thermo Fisher Scientific couldn't pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for Thermo Fisher Scientific's Cash-to-Debt or its related term are showing as below:

TMO' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.04 Med: 0.12 Max: 0.48
Current: 0.23

During the past 13 years, Thermo Fisher Scientific's highest Cash to Debt Ratio was 0.48. The lowest was 0.04. And the median was 0.12.

TMO's Cash-to-Debt is ranked worse than
80.26% of 233 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.44 vs TMO: 0.23

Thermo Fisher Scientific Cash-to-Debt Historical Data

The historical data trend for Thermo Fisher Scientific's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Thermo Fisher Scientific Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

0.14

0.48

0.13

0.25

0.23

Thermo Fisher Scientific Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cash-to-Debt																0.25	0.10	0.09	0.17	0.23

Competitive Comparison

For the Diagnostics & Research subindustry, Thermo Fisher Scientific's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Thermo Fisher Scientific Cash-to-Debt Distribution

For the Medical Diagnostics & Research industry and Healthcare sector, Thermo Fisher Scientific's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Thermo Fisher Scientific's Cash-to-Debt falls into.

Thermo Fisher Scientific Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Thermo Fisher Scientific's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	8077	/	(3609	+	31308)
	=	0.23

Thermo Fisher Scientific's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	8077	/	(3609	+	31308)
	=	0.23

Thermo Fisher Scientific (NYSE:TMO) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Thermo Fisher Scientific Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Thermo Fisher Scientific's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Thermo Fisher Scientific (Thermo Fisher Scientific) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Thermo Fisher Scientific Inc (NYSE:TMO) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

TMO:Peru TMO:Mexico TN8:Germany TN8:Germany TN8:Germany TMOS34:Brazil TMO:Argentina

Address

168 Third Avenue, Waltham, MA, USA, 02451

Website

https://www.thermofisher.com

Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of mid-2023 (revenue figures include some cross-segment revenue): analytical technologies (16% of sales); specialty diagnostic products (10%); life science solutions (24%); and lab products and services, which includes CRO services (54%).

Executives

Marc N Casper	officer: Senior Vice President	C/O THERMO FISHER SCIENTIFIC, 168 THIRD AVENUE, WALTHAM MA 02451
Gianluca Pettiti	officer: Executive Vice President	C/O BUTTERFLY NETWORK, INC., 530 OLD WHITFIELD STREET, GUILFORD CT 06437
Stephen Williamson	officer: Sr. VP and CFO	81 WYMAN STREET, WALTHAM MA 02451
Jennifer M Johnson	director	C/O FRANKLIN RESOURCES, INC., ONE FRANKLIN PARKWAY, SAN MATEO CA 94403-1906
Michael A Boxer	officer: Sr. VP and Gen. Counsel	168 THIRD AVENUE, WALTHAM MA 02451
Lisa P. Britt	officer: Sr. VP and Chief HR Officer	168 THIRD AVENUE, WALTHAM MA 02451
Jim P Manzi	director	81 WYMAN ST, POST OFFICE BOX 9046, WALTHAM MA 02454
Debora L Spar	director	C/O GOLDMAN, SACHS & CO., 200 WEST STREET, NEW YORK NY 10282
Michel Lagarde	officer: Senior Vice President	450 LEXINGTON AVE., 31ST FLOOR, NEW YORK NY 10017
Ruby R Chandy	director	630 DUNDEE ROAD, SUITE 400, NORTHBROOK IL 60062
Mark P Stevenson	officer: Executive Vice President	850 LINCOLN CENTRE DRIVE, FOSTER CITY CA 94404
Joseph R. Holmes	officer: VP & Chief Accounting Officer	168 THIRD AVENUE, WALTHAM MA 02451
R. Alexandra Keith	director	ONE PROCTER & GAMBLE PLAZA, CINCINNATI OH 45202
Peter E Hornstra	officer: Chief Accounting Officer	81 WYMAN ST, POST OFFICE BOX 9046, WALTHAM MA 02454
Syed A. Jafry	officer: Sr. Vice President	345 E. MAIN STREET, WARSAW IN 46580